Pilavapadin

N/A

Report date: 2026/02/14 20:00:22
NME

Base Information

Drug NamePilavapadin
Drug Alias NameBMS-986176LX-9211
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAP2-associated protein kinase 1 inhibitors
TargetsAP2-associated protein kinase 1
Therapy Area/IndicationsDiabetic peripheral neuropathyDiabetes MellitusNeuralgia, Postherpetic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesPoland
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLexicon Pharmaceuticals IncBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesLexicon Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsDiabetic peripheral neuropathyDiabetes MellitusNeuralgia, Postherpetic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A